Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

In vivo administration of TLR9 agonist reduces the severity of experimental autoimmune encephalomyelitis. The role of plasmacytoid dendritic cells and B lymphocytes.

Longhini AL, Santos MP, Pradella F, Moraes AS, Dionete AC, Andrade MD, Russini PG, Oliveira EC, dePaula RO, Morais GA, Fonseca ES, Farias AS, Santos LM.

CNS Neurosci Ther. 2014 Aug;20(8):787-90. doi: 10.1111/cns.12289. No abstract available.

PMID:
24931054
2.

Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.

Zanucoli F, Thomé R, Bonfanti AP, de Carvalho AC, Issayama LK, da Costa TA, Di Gangi R, Ferreira IT, Bombeiro AL, de Oliveira AL, Verinaud L.

CNS Neurosci Ther. 2014 Dec;20(12):1061-4. doi: 10.1111/cns.12357. No abstract available.

PMID:
25417930
3.

B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.

Kala M, Rhodes SN, Piao WH, Shi FD, Campagnolo DI, Vollmer TL.

Exp Neurol. 2010 Jan;221(1):136-45. doi: 10.1016/j.expneurol.2009.10.015.

PMID:
19879259
4.

PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.

Li H, Park D, Abdul-Muneer PM, Xu B, Wang H, Xing B, Wu D, Li S.

Neuroscience. 2013 Dec 3;253:89-99. doi: 10.1016/j.neuroscience.2013.08.051.

PMID:
24012746
5.

Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.

Ge Z, Da Y, Xue Z, Zhang K, Zhuang H, Peng M, Li Y, Li W, Simard A, Hao J, Yao Z, Zhang R.

Exp Neurol. 2013 Mar;241:56-66. doi: 10.1016/j.expneurol.2012.12.006.

PMID:
23261766
6.

β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.

Xu J, Wagoner G, Douglas JC, Drew PD.

J Neuroimmunol. 2013 Jan 15;254(1-2):46-54. doi: 10.1016/j.jneuroim.2012.09.004.

7.

Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.

Clarkson BD, Walker A, Harris M, Rayasam A, Sandor M, Fabry Z.

J Neuroimmunol. 2014 Dec 15;277(1-2):39-49. doi: 10.1016/j.jneuroim.2014.09.016.

8.

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.

Fazio F, Zappulla C, Notartomaso S, Busceti C, Bessede A, Scarselli P, Vacca C, Gargaro M, Volpi C, Allegrucci M, Lionetto L, Simmaco M, Belladonna ML, Nicoletti F, Fallarino F.

Neuropharmacology. 2014 Jun;81:237-43. doi: 10.1016/j.neuropharm.2014.02.011.

PMID:
24565643
9.

Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.

Yin JX, Tang Z, Gan Y, Li L, Shi F, Coons S, Shi J.

Neuropharmacology. 2014 Jun;81:1-5. doi: 10.1016/j.neuropharm.2014.01.027.

PMID:
24486709
10.

Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitis.

McDonald CA, Payne NL, Sun G, Clayton DJ, Del Borgo MP, Aguilar MI, Perlmutter P, Bernard CC.

J Neuroimmunol. 2014 Dec 15;277(1-2):67-76. doi: 10.1016/j.jneuroim.2014.09.022.

PMID:
25454728
11.
12.

Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis.

Williams JL, Kithcart AP, Smith KM, Shawler T, Cox GM, Whitacre CC.

J Neuroimmunol. 2011 May;234(1-2):84-92. doi: 10.1016/j.jneuroim.2011.02.008.

14.
15.
16.

RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.

Lewis ND, Hill JD, Juchem KW, Stefanopoulos DE, Modis LK.

J Neuroimmunol. 2014 Dec 15;277(1-2):26-38. doi: 10.1016/j.jneuroim.2014.09.014.

PMID:
25270668
17.

Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis.

Pifarre P, Prado J, Baltrons MA, Giralt M, Gabarro P, Feinstein DL, Hidalgo J, Garcia A.

Acta Neuropathol. 2011 Apr;121(4):499-508. doi: 10.1007/s00401-010-0795-6.

PMID:
21234581
18.

Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis.

Fitzgerald DC, O'Brien K, Young A, Fonseca-Kelly Z, Rostami A, Gran B.

J Neuroinflammation. 2014 Jul 28;11:130. doi: 10.1186/1742-2094-11-130.

20.

The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis.

Bittner S, Bauer MA, Ehling P, Bobak N, Breuer J, Herrmann AM, Golfels M, Wiendl H, Budde T, Meuth SG.

Exp Neurol. 2012 Dec;238(2):149-55. doi: 10.1016/j.expneurol.2012.08.021.

PMID:
22960185
Items per page

Supplemental Content

Support Center